[
  {
    "ts": null,
    "headline": "Dow Jones Futures: It's A Broad, Strong Rally, Do Your Stocks Reflect That? JPMorgan, Goldman, Delta, Taiwan Semi Loom",
    "summary": "The stock market is at highs with JPMorgan, Goldman, Taiwan Semi and Delta earnings due. Two huge conferences, inflation data and perhaps a Trump tariffs ruling also are on tap.",
    "url": "https://finnhub.io/api/news?id=0c98e861c19f0392bf6b86daf66121c037d0cb83309a5b41c6ac2687a289af10",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768001877,
      "headline": "Dow Jones Futures: It's A Broad, Strong Rally, Do Your Stocks Reflect That? JPMorgan, Goldman, Delta, Taiwan Semi Loom",
      "id": 138052040,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "The stock market is at highs with JPMorgan, Goldman, Taiwan Semi and Delta earnings due. Two huge conferences, inflation data and perhaps a Trump tariffs ruling also are on tap.",
      "url": "https://finnhub.io/api/news?id=0c98e861c19f0392bf6b86daf66121c037d0cb83309a5b41c6ac2687a289af10"
    }
  },
  {
    "ts": null,
    "headline": "Can Strong Earnings Justify High Stock Valuations?",
    "summary": "With the 2025 Q4 earnings season about to begin, we discuss how critical the overall earnings picture is to the stock market.",
    "url": "https://finnhub.io/api/news?id=f0173db244971fef855efd34a1d326c2de1b7a96f9beba20c76462b194a4ac78",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767992580,
      "headline": "Can Strong Earnings Justify High Stock Valuations?",
      "id": 138052193,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "With the 2025 Q4 earnings season about to begin, we discuss how critical the overall earnings picture is to the stock market.",
      "url": "https://finnhub.io/api/news?id=f0173db244971fef855efd34a1d326c2de1b7a96f9beba20c76462b194a4ac78"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan (JPM)’s Multiple is an Insult to CEO Jamie Dimon, Says Jim Cramer",
    "summary": "We recently published 11 Stocks on Jim Cramer’s Radar. JPMorgan Chase & Co. (NYSE:JPM) is one of the stocks on Jim Cramer radar. Banking giant JPMorgan Chase & Co. (NYSE:JPM) crossed Jim Cramer’s radar after he discussed a Barclays note for Citigroup. Barclays bumped up Citi’s share price target, and its coverage came after a similar […]",
    "url": "https://finnhub.io/api/news?id=3b7cfd035041b33a6fb648993cf90089625acf5f17262dde1b178a6e561252c4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767987995,
      "headline": "JPMorgan (JPM)’s Multiple is an Insult to CEO Jamie Dimon, Says Jim Cramer",
      "id": 138052194,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "We recently published 11 Stocks on Jim Cramer’s Radar. JPMorgan Chase & Co. (NYSE:JPM) is one of the stocks on Jim Cramer radar. Banking giant JPMorgan Chase & Co. (NYSE:JPM) crossed Jim Cramer’s radar after he discussed a Barclays note for Citigroup. Barclays bumped up Citi’s share price target, and its coverage came after a similar […]",
      "url": "https://finnhub.io/api/news?id=3b7cfd035041b33a6fb648993cf90089625acf5f17262dde1b178a6e561252c4"
    }
  },
  {
    "ts": null,
    "headline": "Jamie Dimon's Grip On US Credit Card Dominance Grows As JPMorgan Wins Apple Card Business From Goldman Sachs",
    "summary": "Apple Inc. (NASDAQ:AAPL) has chosen JPMorgan Chase (NYSE:JPM) as the new issuer of the Apple Card, ending Goldman Sachs' (NYSE:GS) role in a move that significantly reshapes the consumer finance ambitions of all three companies. JPMorgan Chase Takes Over Apple Card From Goldman Sachs On Wednesday, JPMorgan Chase announced that it has reached an agreement with Apple to become the new issuer of the Apple Card, replacing Goldman Sachs. The deal expands the largest U.S. bank's already massive credit",
    "url": "https://finnhub.io/api/news?id=4b9caf4a79e69692899932534b8518f89c84ada849f42e19d19ac6fc82d5b35d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767987073,
      "headline": "Jamie Dimon's Grip On US Credit Card Dominance Grows As JPMorgan Wins Apple Card Business From Goldman Sachs",
      "id": 138049262,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Apple Inc. (NASDAQ:AAPL) has chosen JPMorgan Chase (NYSE:JPM) as the new issuer of the Apple Card, ending Goldman Sachs' (NYSE:GS) role in a move that significantly reshapes the consumer finance ambitions of all three companies. JPMorgan Chase Takes Over Apple Card From Goldman Sachs On Wednesday, JPMorgan Chase announced that it has reached an agreement with Apple to become the new issuer of the Apple Card, replacing Goldman Sachs. The deal expands the largest U.S. bank's already massive credit",
      "url": "https://finnhub.io/api/news?id=4b9caf4a79e69692899932534b8518f89c84ada849f42e19d19ac6fc82d5b35d"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer says don’t trade Apple and Nvidia as money rotates into overlooked stocks ahead of earnings season",
    "summary": "Jim Cramer says a broad market rally is underway, with money rotating out of Apple and Nvidia and into overlooked stocks ahead of earnings season.",
    "url": "https://finnhub.io/api/news?id=3a0779d04224c658a3decaf2dea43f2c985a332b942b20b8923c9394e4d942b2",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767985306,
      "headline": "Jim Cramer says don’t trade Apple and Nvidia as money rotates into overlooked stocks ahead of earnings season",
      "id": 138057104,
      "image": "https://image.cnbcfm.com/api/v1/image/108208974-1759860674930-dsc_6122.jpg?v=1759867950&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "Jim Cramer says a broad market rally is underway, with money rotating out of Apple and Nvidia and into overlooked stocks ahead of earnings season.",
      "url": "https://finnhub.io/api/news?id=3a0779d04224c658a3decaf2dea43f2c985a332b942b20b8923c9394e4d942b2"
    }
  },
  {
    "ts": null,
    "headline": "Umicore - Transparency notification by JP Morgan Asset Management Holdings Inc.",
    "summary": "Transparency notification by JP Morgan Asset Management Holdings Inc. In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by JP Morgan Asset Management Holdings Inc. that its subsidiary JP Morgan Asset Management (UK) Limited has crossed the legal threshold of 3% for the direct voting rights and equivalent financial instruments upwards on 5 January 2026. The total holding of direct voting rights and equivalent financial i",
    "url": "https://finnhub.io/api/news?id=2df671904803d7309858ebd54534a3d10344298a697de4e343b59c5129e7ba12",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767979800,
      "headline": "Umicore - Transparency notification by JP Morgan Asset Management Holdings Inc.",
      "id": 138052196,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Transparency notification by JP Morgan Asset Management Holdings Inc. In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by JP Morgan Asset Management Holdings Inc. that its subsidiary JP Morgan Asset Management (UK) Limited has crossed the legal threshold of 3% for the direct voting rights and equivalent financial instruments upwards on 5 January 2026. The total holding of direct voting rights and equivalent financial i",
      "url": "https://finnhub.io/api/news?id=2df671904803d7309858ebd54534a3d10344298a697de4e343b59c5129e7ba12"
    }
  },
  {
    "ts": null,
    "headline": "Goldman Projects 46-Cent EPS Gain in Q4 From Apple Card Transition",
    "summary": "GS expects a 46-cent EPS boost in 4Q25 as it exits the Apple Card, releasing reserves amid a 24-month transition of the program to JPMorgan.",
    "url": "https://finnhub.io/api/news?id=1561cb2aed7c9b786f86911dbb9df76ed6ccb56dc1ccb7070b023c50fef873ff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767978900,
      "headline": "Goldman Projects 46-Cent EPS Gain in Q4 From Apple Card Transition",
      "id": 138049271,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "GS expects a 46-cent EPS boost in 4Q25 as it exits the Apple Card, releasing reserves amid a 24-month transition of the program to JPMorgan.",
      "url": "https://finnhub.io/api/news?id=1561cb2aed7c9b786f86911dbb9df76ed6ccb56dc1ccb7070b023c50fef873ff"
    }
  },
  {
    "ts": null,
    "headline": "Banks eye Venezuela investment, JPMorgan seen with advantage",
    "summary": "NEW YORK/HOUSTON, Jan 9 (Reuters) - The U. involvement in Venezuela's oil sector offers a potential opportunity for international banks, with JPMorgan Chase in an advantageous spot due to its history in the country and past involvement with international trade financing.",
    "url": "https://finnhub.io/api/news?id=2670dfbab8c8b5d27aa11d7d0fde0cb5bda515b7d44e8bf612111cf4f1c59524",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767977586,
      "headline": "Banks eye Venezuela investment, JPMorgan seen with advantage",
      "id": 138052198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "NEW YORK/HOUSTON, Jan 9 (Reuters) - The U. involvement in Venezuela's oil sector offers a potential opportunity for international banks, with JPMorgan Chase in an advantageous spot due to its history in the country and past involvement with international trade financing.",
      "url": "https://finnhub.io/api/news?id=2670dfbab8c8b5d27aa11d7d0fde0cb5bda515b7d44e8bf612111cf4f1c59524"
    }
  },
  {
    "ts": null,
    "headline": "JPM double-upgrades Southwest Airlines shares, sets new street high price target",
    "summary": "Investing.com -- JPMorgan double-upgraded Southwest Airlines to Overweight from Underweight this week, arguing that the carrier’s upcoming 2026 guidance could mark a turning point for both sentiment and valuation.",
    "url": "https://finnhub.io/api/news?id=1c854ee733109846979f2e4812cfc819c35dcfa979435aff38da03505094d0e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767975746,
      "headline": "JPM double-upgrades Southwest Airlines shares, sets new street high price target",
      "id": 138052199,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Investing.com -- JPMorgan double-upgraded Southwest Airlines to Overweight from Underweight this week, arguing that the carrier’s upcoming 2026 guidance could mark a turning point for both sentiment and valuation.",
      "url": "https://finnhub.io/api/news?id=1c854ee733109846979f2e4812cfc819c35dcfa979435aff38da03505094d0e7"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan Stock, This AI Chip Leader Kick Off Earnings Season",
    "summary": "JPMorgan stock headlines a busy week of earnings reports in the financial sector. Results are also due from AI leader Taiwan Semiconductor.",
    "url": "https://finnhub.io/api/news?id=90721efe5ece694111959e23ff700f65583620ac7b3a121c45d43d40edf0803f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767975709,
      "headline": "JPMorgan Stock, This AI Chip Leader Kick Off Earnings Season",
      "id": 138048033,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "JPMorgan stock headlines a busy week of earnings reports in the financial sector. Results are also due from AI leader Taiwan Semiconductor.",
      "url": "https://finnhub.io/api/news?id=90721efe5ece694111959e23ff700f65583620ac7b3a121c45d43d40edf0803f"
    }
  },
  {
    "ts": null,
    "headline": "JPM Raises PT on Taiwan Semiconductor Manufacturing Company Limited (TSM), Keeps a Buy",
    "summary": "Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the Best Unstoppable Growth Stocks to Buy Right Now. The share price of TSM rose more than 54% last year, and Wall Street sees further growth with an analyst 12-month price target suggesting around 10% upside from the current level. Recently, on December 7, JPMorgan raised […]",
    "url": "https://finnhub.io/api/news?id=79295dd379a2dd101c24ebaa4b13755422d84e2e1beca4cf9c80f007acef1db7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767974071,
      "headline": "JPM Raises PT on Taiwan Semiconductor Manufacturing Company Limited (TSM), Keeps a Buy",
      "id": 138046629,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the Best Unstoppable Growth Stocks to Buy Right Now. The share price of TSM rose more than 54% last year, and Wall Street sees further growth with an analyst 12-month price target suggesting around 10% upside from the current level. Recently, on December 7, JPMorgan raised […]",
      "url": "https://finnhub.io/api/news?id=79295dd379a2dd101c24ebaa4b13755422d84e2e1beca4cf9c80f007acef1db7"
    }
  },
  {
    "ts": null,
    "headline": "Why The Narrative Around Smith Douglas Homes (SDHC) Is Shifting After JPMorgan’s Trimmed Target",
    "summary": "Why the Price Target Shifted While the Core Valuation Stayed Put Smith Douglas Homes is back in focus as JPMorgan trims its price target to $17 from $18, even while the fair value anchor used in the model holds steady at $16.75. Behind that move, the key building blocks of the narrative, including the discount rate and revenue growth assumptions, have only inched around the edges rather than being overhauled. That small reset sits alongside commentary that still flags solid return on equity...",
    "url": "https://finnhub.io/api/news?id=5e509cd87d7d928b80d7aa4643c2f5c8fa1b5dca9d3a88cce64b5c35f72328b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767971711,
      "headline": "Why The Narrative Around Smith Douglas Homes (SDHC) Is Shifting After JPMorgan’s Trimmed Target",
      "id": 138046630,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Why the Price Target Shifted While the Core Valuation Stayed Put Smith Douglas Homes is back in focus as JPMorgan trims its price target to $17 from $18, even while the fair value anchor used in the model holds steady at $16.75. Behind that move, the key building blocks of the narrative, including the discount rate and revenue growth assumptions, have only inched around the edges rather than being overhauled. That small reset sits alongside commentary that still flags solid return on equity...",
      "url": "https://finnhub.io/api/news?id=5e509cd87d7d928b80d7aa4643c2f5c8fa1b5dca9d3a88cce64b5c35f72328b7"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to watch next week: JPMorgan, Goldman Sachs, TSMC, Persimmon and Vistry",
    "summary": "Earnings preview of key companies reporting this week and what to look out for.",
    "url": "https://finnhub.io/api/news?id=cca1fe3a0d35f981303fc65682be369b266b699f7f012df2415c9212f42222c4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767970746,
      "headline": "Stocks to watch next week: JPMorgan, Goldman Sachs, TSMC, Persimmon and Vistry",
      "id": 138046631,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Earnings preview of key companies reporting this week and what to look out for.",
      "url": "https://finnhub.io/api/news?id=cca1fe3a0d35f981303fc65682be369b266b699f7f012df2415c9212f42222c4"
    }
  },
  {
    "ts": null,
    "headline": "Banks to report earnings next week: 3 things investors are watching",
    "summary": "Earnings season is close to kicking off for big banks, with companies JPMorgan Chase (JPM), Bank of America (BAC), Citigroup (C), Morgan Stanley (MS), Wells Fargo (WFC), and Goldman Sachs (GS) set to report their quarterly results throughout next week. Major US bank stocks notably ended 2025 at new record highs. Yahoo Finance senior bank reporter David Hollerith lists the three biggest themes that Wall Street investors will be watching from bank earnings. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
    "url": "https://finnhub.io/api/news?id=d5741c40e91938200665b3c522c4e140ca2190e3783ab615527682fa7f323833",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767970425,
      "headline": "Banks to report earnings next week: 3 things investors are watching",
      "id": 138046632,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Earnings season is close to kicking off for big banks, with companies JPMorgan Chase (JPM), Bank of America (BAC), Citigroup (C), Morgan Stanley (MS), Wells Fargo (WFC), and Goldman Sachs (GS) set to report their quarterly results throughout next week. Major US bank stocks notably ended 2025 at new record highs. Yahoo Finance senior bank reporter David Hollerith lists the three biggest themes that Wall Street investors will be watching from bank earnings. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
      "url": "https://finnhub.io/api/news?id=d5741c40e91938200665b3c522c4e140ca2190e3783ab615527682fa7f323833"
    }
  },
  {
    "ts": null,
    "headline": "JPM Q4 Earnings on Deck: Buy, Sell or Hold the Stock Ahead of Results?",
    "summary": "JPMorgan's Q4 earnings preview shows strength in trading and lending, but expenses and valuation may weigh on investor sentiment.",
    "url": "https://finnhub.io/api/news?id=cefe87668466144ad9794c1ab56a03ee277e980daaea4e0acfc83246d3cf012c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767967200,
      "headline": "JPM Q4 Earnings on Deck: Buy, Sell or Hold the Stock Ahead of Results?",
      "id": 138046657,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "JPMorgan's Q4 earnings preview shows strength in trading and lending, but expenses and valuation may weigh on investor sentiment.",
      "url": "https://finnhub.io/api/news?id=cefe87668466144ad9794c1ab56a03ee277e980daaea4e0acfc83246d3cf012c"
    }
  },
  {
    "ts": null,
    "headline": "Is The Apple Card Deal Really A Triple Win?",
    "summary": "JPMorgan to buy Apple Cardâs $20B portfolio from Goldman at a discountâriskier with 34% subprime exposure.",
    "url": "https://finnhub.io/api/news?id=75ef2ed00d1b302cb566be14c50bda4e546f26a76b208174f51e88b21ca43c33",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767966894,
      "headline": "Is The Apple Card Deal Really A Triple Win?",
      "id": 138048628,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1371043536/image_1371043536.jpg?io=getty-c-w1536",
      "related": "JPM",
      "source": "SeekingAlpha",
      "summary": "JPMorgan to buy Apple Cardâs $20B portfolio from Goldman at a discountâriskier with 34% subprime exposure.",
      "url": "https://finnhub.io/api/news?id=75ef2ed00d1b302cb566be14c50bda4e546f26a76b208174f51e88b21ca43c33"
    }
  },
  {
    "ts": null,
    "headline": "Taiwan Semiconductor Started 2nm Chip Production. Time to Buy?",
    "summary": "Taiwan Semiconductor Manufacturing (NYSE:TSM) shares have been unstoppable in the past year, gaining more than 52%, thanks in part to a handful of incredible quarters. The big 2025 winner has what it takes to keep on winning in the new year, so say analysts over at JP Morgan. With 2nm chip production kicking off just ... Taiwan Semiconductor Started 2nm Chip Production. Time to Buy?",
    "url": "https://finnhub.io/api/news?id=e3651f8ca0e61f509871b1663c7c2b8c2adc95d1a67a7676efad17e57d3c15cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767966568,
      "headline": "Taiwan Semiconductor Started 2nm Chip Production. Time to Buy?",
      "id": 138046633,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Taiwan Semiconductor Manufacturing (NYSE:TSM) shares have been unstoppable in the past year, gaining more than 52%, thanks in part to a handful of incredible quarters. The big 2025 winner has what it takes to keep on winning in the new year, so say analysts over at JP Morgan. With 2nm chip production kicking off just ... Taiwan Semiconductor Started 2nm Chip Production. Time to Buy?",
      "url": "https://finnhub.io/api/news?id=e3651f8ca0e61f509871b1663c7c2b8c2adc95d1a67a7676efad17e57d3c15cb"
    }
  },
  {
    "ts": null,
    "headline": "CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "BERKELEY HEIGHTS, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that Joseph Todisco, Chairman and CEO of CorMedix Therapeutics, will present a corporate overview at the 44th annual J.P. Morgan Healthcare Conference. The presentation is scheduled to take place on Monday, January 12, 2026 at 4:30pm PST. 44th Annual",
    "url": "https://finnhub.io/api/news?id=10cd60cab48bb63fb585deb59964ce143ba07b518cdc0d1904eb6b142ba35bce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767965400,
      "headline": "CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138045452,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "BERKELEY HEIGHTS, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that Joseph Todisco, Chairman and CEO of CorMedix Therapeutics, will present a corporate overview at the 44th annual J.P. Morgan Healthcare Conference. The presentation is scheduled to take place on Monday, January 12, 2026 at 4:30pm PST. 44th Annual",
      "url": "https://finnhub.io/api/news?id=10cd60cab48bb63fb585deb59964ce143ba07b518cdc0d1904eb6b142ba35bce"
    }
  },
  {
    "ts": null,
    "headline": "Fiserv: Potentially In A Bottoming Process",
    "summary": "Fiserv (FISV) stock plunged 70% and FY25 guidance reset.",
    "url": "https://finnhub.io/api/news?id=a1e7f5530265f365630da945e31e0b63dd4badff90a7accd50a181ce8ead81b7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767964021,
      "headline": "Fiserv: Potentially In A Bottoming Process",
      "id": 138048225,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2190107128/image_2190107128.jpg?io=getty-c-w1536",
      "related": "JPM",
      "source": "SeekingAlpha",
      "summary": "Fiserv (FISV) stock plunged 70% and FY25 guidance reset.",
      "url": "https://finnhub.io/api/news?id=a1e7f5530265f365630da945e31e0b63dd4badff90a7accd50a181ce8ead81b7"
    }
  },
  {
    "ts": null,
    "headline": "iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference",
    "summary": "iOnctura, a clinical-stage biopharmaceutical company developing precision oral small molecules for neglected and hard-to-treat cancers, today announces that its Chief Executive Officer, Catherine Pickering, will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12–15, 2026, in San Francisco, California.",
    "url": "https://finnhub.io/api/news?id=91c83bfe504f6844c8d321b2d4bbecdd7f04ea6b92d6970ae3b2df137c3dd759",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767963720,
      "headline": "iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference",
      "id": 138045453,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "iOnctura, a clinical-stage biopharmaceutical company developing precision oral small molecules for neglected and hard-to-treat cancers, today announces that its Chief Executive Officer, Catherine Pickering, will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12–15, 2026, in San Francisco, California.",
      "url": "https://finnhub.io/api/news?id=91c83bfe504f6844c8d321b2d4bbecdd7f04ea6b92d6970ae3b2df137c3dd759"
    }
  },
  {
    "ts": null,
    "headline": "Best savings account deals for 2026",
    "summary": "Check the best savings accounts to find a top-rated deal that works for you.",
    "url": "https://finnhub.io/api/news?id=89e57220545215a463c5a581f98eff7f559f3da34d9efe44eb8547e4a248bb45",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767963708,
      "headline": "Best savings account deals for 2026",
      "id": 138045454,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Check the best savings accounts to find a top-rated deal that works for you.",
      "url": "https://finnhub.io/api/news?id=89e57220545215a463c5a581f98eff7f559f3da34d9efe44eb8547e4a248bb45"
    }
  },
  {
    "ts": null,
    "headline": "Averna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Averna Therapeutics, Inc., a biotechnology company developing novel genomic medicines based on gene insertion technology, today announced that Tom Barnes, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026, at 10:00 AM PT in San Francisco.",
    "url": "https://finnhub.io/api/news?id=4298ddd86a18c1d3f688763ec99d24b4b83cf2b92411eb2d17abb378b6ef576d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767963600,
      "headline": "Averna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138045455,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Averna Therapeutics, Inc., a biotechnology company developing novel genomic medicines based on gene insertion technology, today announced that Tom Barnes, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026, at 10:00 AM PT in San Francisco.",
      "url": "https://finnhub.io/api/news?id=4298ddd86a18c1d3f688763ec99d24b4b83cf2b92411eb2d17abb378b6ef576d"
    }
  },
  {
    "ts": null,
    "headline": "Healthy Returns: What to expect from pharma at the JPM conference",
    "summary": "At the JPMorgan Healthcare Conference, drugmakers are expected to roll out key business and drug pipeline updates and splashy M&A deals.",
    "url": "https://finnhub.io/api/news?id=b176745a81fadd629d60d2032e94bcf615335731dd1a1757a1b83c37313be307",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767963421,
      "headline": "Healthy Returns: What to expect from pharma at the JPM conference",
      "id": 138057238,
      "image": "https://image.cnbcfm.com/api/v1/image/108222520-17624504352025-11-06t173326z_182594845_rc24rhaozaeo_rtrmadp_0_usa-trump.jpeg?v=1767995336&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "At the JPMorgan Healthcare Conference, drugmakers are expected to roll out key business and drug pipeline updates and splashy M&A deals.",
      "url": "https://finnhub.io/api/news?id=b176745a81fadd629d60d2032e94bcf615335731dd1a1757a1b83c37313be307"
    }
  },
  {
    "ts": null,
    "headline": "Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today provided an update on the Company's commercial and clinical programs and its outlook for 2026. These updates will be discussed as part of the Company's presentation at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026, at 3:00 p.m. PT (6:00 p.m. ET).",
    "url": "https://finnhub.io/api/news?id=e03c65a5a48e0b5c83d1fa670b483affa6495e781b02dba5e801b7d6ff300f3f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767960000,
      "headline": "Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138045457,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today provided an update on the Company's commercial and clinical programs and its outlook for 2026. These updates will be discussed as part of the Company's presentation at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026, at 3:00 p.m. PT (6:00 p.m. ET).",
      "url": "https://finnhub.io/api/news?id=e03c65a5a48e0b5c83d1fa670b483affa6495e781b02dba5e801b7d6ff300f3f"
    }
  },
  {
    "ts": null,
    "headline": "Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US community and global market penetration Enrolling three Phase 3 trials across multiple melanoma indications – TEBE-AM enrollment completion anticipated 1H 2026; topline data expected as early as 2H 2026 PRAME franchise Phase 1/2 data to be presented in 2H 2026: brenetafusp combinations in ovarian and lung c",
    "url": "https://finnhub.io/api/news?id=f130c66e63ac92f08ab4da5faf7ad6483fdf99946c58f4db0d0637be5f67301f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767960000,
      "headline": "Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138045456,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US community and global market penetration Enrolling three Phase 3 trials across multiple melanoma indications – TEBE-AM enrollment completion anticipated 1H 2026; topline data expected as early as 2H 2026 PRAME franchise Phase 1/2 data to be presented in 2H 2026: brenetafusp combinations in ovarian and lung c",
      "url": "https://finnhub.io/api/news?id=f130c66e63ac92f08ab4da5faf7ad6483fdf99946c58f4db0d0637be5f67301f"
    }
  },
  {
    "ts": null,
    "headline": "J.P. Morgan Bangs the Drum on These 2 ‘Strong Buy’ Stocks",
    "summary": "We’ve turned the calendar on 2026, and the market’s focus is on what comes next. The big questions haven’t changed: can the bull run extend into the new year? Is AI showing signs of a bubble, or is it still in the early innings? And will the Fed continue cutting rates? The answers to these will shape market direction in the months ahead and well into the year. Ken Goldman of the JPMorgan’s Americas Equity Research team argues that resilient fundamentals and easing financial conditions support fu",
    "url": "https://finnhub.io/api/news?id=84e4b02d6d226314cf16e1be8fb676d520a34c4eb4f31ca74a99b19b71eedcad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767956677,
      "headline": "J.P. Morgan Bangs the Drum on These 2 ‘Strong Buy’ Stocks",
      "id": 138045459,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "We’ve turned the calendar on 2026, and the market’s focus is on what comes next. The big questions haven’t changed: can the bull run extend into the new year? Is AI showing signs of a bubble, or is it still in the early innings? And will the Fed continue cutting rates? The answers to these will shape market direction in the months ahead and well into the year. Ken Goldman of the JPMorgan’s Americas Equity Research team argues that resilient fundamentals and easing financial conditions support fu",
      "url": "https://finnhub.io/api/news?id=84e4b02d6d226314cf16e1be8fb676d520a34c4eb4f31ca74a99b19b71eedcad"
    }
  },
  {
    "ts": null,
    "headline": "How To Earn $500 A Month From JPMorgan Stock Ahead Of Q4 Earnings",
    "summary": "JPMorgan Chase & Co. (NYSE:JPM) will release earnings results for the fourth quarter, before the opening bell on Tuesday, Jan. 13, 2025. Analysts expect the bank to report quarterly earnings at $5.01 per share, up from $4.81 per share in the year-ago period. The consensus estimate for JPMorgan's quarterly revenue is $46.25 billion, up from $42.77 billion a year earlier, according to data from Benzinga Pro. With the recent buzz around JPMorgan, some investors may be eyeing potential gains from th",
    "url": "https://finnhub.io/api/news?id=b58a7caa09c0754d6db2c4ccbb4bf3965636b4a05c39ca7694b9bd322d70722d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767955568,
      "headline": "How To Earn $500 A Month From JPMorgan Stock Ahead Of Q4 Earnings",
      "id": 138044478,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "JPMorgan Chase & Co. (NYSE:JPM) will release earnings results for the fourth quarter, before the opening bell on Tuesday, Jan. 13, 2025. Analysts expect the bank to report quarterly earnings at $5.01 per share, up from $4.81 per share in the year-ago period. The consensus estimate for JPMorgan's quarterly revenue is $46.25 billion, up from $42.77 billion a year earlier, according to data from Benzinga Pro. With the recent buzz around JPMorgan, some investors may be eyeing potential gains from th",
      "url": "https://finnhub.io/api/news?id=b58a7caa09c0754d6db2c4ccbb4bf3965636b4a05c39ca7694b9bd322d70722d"
    }
  },
  {
    "ts": null,
    "headline": "How Recent Moves Are Rewriting The Story For Archer Daniels Midland ADM",
    "summary": "Archer Daniels Midland just saw its fair value estimate edge to about US$57.09 per share, a very small change that keeps the stock in roughly the same price range even as the story around its earnings outlook becomes more debated. With Q3 earnings ahead of estimates and a fresh US$59 price target from JPMorgan, the latest update reflects a balance between support from recent results and caution around profit headwinds that analysts continue to flag. Read on to see how you can keep track of...",
    "url": "https://finnhub.io/api/news?id=f3c61d654dbe7bdb1d162487c50f67b27c45ad97b91e802e9d44d5ba70bfec86",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767946644,
      "headline": "How Recent Moves Are Rewriting The Story For Archer Daniels Midland ADM",
      "id": 138044512,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Archer Daniels Midland just saw its fair value estimate edge to about US$57.09 per share, a very small change that keeps the stock in roughly the same price range even as the story around its earnings outlook becomes more debated. With Q3 earnings ahead of estimates and a fresh US$59 price target from JPMorgan, the latest update reflects a balance between support from recent results and caution around profit headwinds that analysts continue to flag. Read on to see how you can keep track of...",
      "url": "https://finnhub.io/api/news?id=f3c61d654dbe7bdb1d162487c50f67b27c45ad97b91e802e9d44d5ba70bfec86"
    }
  },
  {
    "ts": null,
    "headline": "Exxon Mobil: America's Invasion Could Be Your Persuasion To Invest In This Dividend Aristocrat",
    "summary": "Exxon Mobil (XOM) could gain from new Venezuela access, boosting reserves and growth for the dividend payer. Read the latest analysis on the stock here.",
    "url": "https://finnhub.io/api/news?id=fbd686370044db0a515c600fabb9b935adee14ecc44a6c05bf287857ad2d6e42",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767943800,
      "headline": "Exxon Mobil: America's Invasion Could Be Your Persuasion To Invest In This Dividend Aristocrat",
      "id": 138044952,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2187036324/image_2187036324.jpg?io=getty-c-w1536",
      "related": "JPM",
      "source": "SeekingAlpha",
      "summary": "Exxon Mobil (XOM) could gain from new Venezuela access, boosting reserves and growth for the dividend payer. Read the latest analysis on the stock here.",
      "url": "https://finnhub.io/api/news?id=fbd686370044db0a515c600fabb9b935adee14ecc44a6c05bf287857ad2d6e42"
    }
  },
  {
    "ts": null,
    "headline": "How The Narrative Around Rightmove (LSE:RMV) Is Shifting With AI Plans And Downgrades",
    "summary": "Rightmove’s latest valuation work keeps the core fair value anchor steady at £6.57 per share, even as the surrounding narrative has become more cautious with a series of price target cuts and rating downgrades. Analysts are rethinking how much risk to attach to the new artificial intelligence driven plan and a tougher competitive backdrop, which helps explain why targets, such as JPMorgan’s moves from £6.27 to £5.55 and then to £5.00, have been reset even without a change to the central fair...",
    "url": "https://finnhub.io/api/news?id=4c648ab96c87a7047674720ee0f499adf3165d74c263c4229162a6bd50d29d9e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767924848,
      "headline": "How The Narrative Around Rightmove (LSE:RMV) Is Shifting With AI Plans And Downgrades",
      "id": 138043035,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Rightmove’s latest valuation work keeps the core fair value anchor steady at £6.57 per share, even as the surrounding narrative has become more cautious with a series of price target cuts and rating downgrades. Analysts are rethinking how much risk to attach to the new artificial intelligence driven plan and a tougher competitive backdrop, which helps explain why targets, such as JPMorgan’s moves from £6.27 to £5.55 and then to £5.00, have been reset even without a change to the central fair...",
      "url": "https://finnhub.io/api/news?id=4c648ab96c87a7047674720ee0f499adf3165d74c263c4229162a6bd50d29d9e"
    }
  },
  {
    "ts": null,
    "headline": "What Analysts Think Is Changing The Story For Amazon.com (AMZN)",
    "summary": "Amazon.com’s modeled fair value has barely moved, shifting from about US$295.53 to about US$295.51 per share, even as the discount rate, long term revenue growth assumptions and views around AI related cloud demand, advertising and retail all continue to be debated. This tiny change reflects how bullish arguments around large AI infrastructure deals and advertising momentum are being weighed against concerns about heavier capital spending and cloud economics. As these cross currents keep...",
    "url": "https://finnhub.io/api/news?id=81a2cd291f349a2bdf579637e6f82bbc0e674d9e3cfc47df3a1f3c4123ec1d47",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767924568,
      "headline": "What Analysts Think Is Changing The Story For Amazon.com (AMZN)",
      "id": 138042957,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Amazon.com’s modeled fair value has barely moved, shifting from about US$295.53 to about US$295.51 per share, even as the discount rate, long term revenue growth assumptions and views around AI related cloud demand, advertising and retail all continue to be debated. This tiny change reflects how bullish arguments around large AI infrastructure deals and advertising momentum are being weighed against concerns about heavier capital spending and cloud economics. As these cross currents keep...",
      "url": "https://finnhub.io/api/news?id=81a2cd291f349a2bdf579637e6f82bbc0e674d9e3cfc47df3a1f3c4123ec1d47"
    }
  }
]